Your browser doesn't support javascript.
COVID-19 Pulmonary Failure and Extracorporeal Membrane Oxygenation: First Experience from Three European Extracorporeal Membrane Oxygenation Centers.
Yankah, Charles Abraham; Trimlett, Richard; Sandoval, Elena; Lotz, Christopher; Ledot, Stephane; Pomar, Jose Luis; Price, Susanna; Meybohm, Patrick.
  • Yankah CA; Department of Thoracic and Cardiovascular Surgery, Deutsches Herzzentrum Berlin/Charité, Berlin, Germany.
  • Trimlett R; Department of International Relations, Pan-African Society for Cardiothoracic Surgery, Berlin, Germany.
  • Sandoval E; Department of Cardiac Surgery, Royal Brompton Hospital, London, United Kingdom of Great Britain and Northern Ireland.
  • Lotz C; Department of Cardiac Surgery, Clinic Barcelona Hospital University, Barcelona, Spain.
  • Ledot S; Department of Anaesthesiology and Intensive Care Medicine, University Hospital Wurzburg, Wurzburg, Bayern, Germany.
  • Pomar JL; Department of Intensive Care Medicine, Royal Brompton and Harefield NHS Trust, London, United Kingdom of Great Britain and Northern Ireland.
  • Price S; Department of Cardiac Surgery, Clinic Barcelona Hospital University, Barcelona, Spain.
  • Meybohm P; Department of Cardiac Surgery, Barnaclinic, Barcelona, Spain.
Thorac Cardiovasc Surg ; 69(3): 259-262, 2021 04.
Article in English | MEDLINE | ID: covidwho-927094
ABSTRACT
On April 17, 2020, a coronavirus disease 2019 (COVID-19) webinar was held by selected international experts in the field of intensive care and specialized respiratory ECMO centers from Germany, Italy, Spain, and the United Kingdom, which was hosted by the German Heart Centre Berlin/Charité. The experts shared their experience about the treatment of 42 patients with severe acute respiratory failure requiring venovenous extracorporeal membrane oxygenation (VV-ECMO). Patients were predominantly male (male-to-female ratio 31), with a mean age of 51 years (range 25-73 years). VV-ECMO support was indicated in 30% of the ventilated COVID-19 patients. The mean time requiring mechanical ventilation was 16.5 days, with a mean duration of ECMO support of 10.6 days. At the time of the webinar, a total of 17 patients had already been decannulated from ECMO, whereas six died with multiorgan failure. 18 patients remained on ECMO, with their final outcomes unknown at the time of the webinar. Hospital mortality was 25.6% (as of April 17, 2020). In this respect, VV-ECMO, provided by expert centers, is a recognized and validated mode of advanced life-support during the recent COVID-19 pandemic with good outcomes.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Extracorporeal Membrane Oxygenation / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Thorac Cardiovasc Surg Year: 2021 Document Type: Article Affiliation country: S-0040-1719156

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Extracorporeal Membrane Oxygenation / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Thorac Cardiovasc Surg Year: 2021 Document Type: Article Affiliation country: S-0040-1719156